Search research articles
Contact Us
Filters
Showing results (461-470 of 510) with videos related to
Page
of 51
Sort By:
Current Biology : CB
|
August 30, 2001
A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells
O T Fackler, D Wolf, H O Weber, et al.
Journal of Immunological Methods
|
October 24, 2000
A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use
B Feuerstein, T G Berger, C Maczek, et al.
British Journal of Cancer
|
March 1, 2002
Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)
J Atzpodien, K Neuber, D Kamanabrou, et al.
Der Radiologe
|
October 17, 2013
[Imaging prior to transcatheter aortic valve implantation]
M Gutberlet, B Foldyna, M Grothoff, et al.
The British Journal of Dermatology
|
July 15, 2017
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients
Y Teramoto, U Keim, A Gesierich, et al.
The Journal of Experimental Medicine
|
December 10, 1999
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
B Thurner, I Haendle, C Röder, et al.
Science (New York, N.Y.)
|
January 5, 1999
The transcriptional program in the response of human fibroblasts to serum
V R Iyer, M B Eisen, D T Ross, et al.
Journal of Cancer Research and Clinical Oncology
|
June 16, 2017
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab
C Brüggemann, M C Kirchberger, S M Goldinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells
B Schuler-Thurner, D Dieckmann, P Keikavoussi, et al.
Astrobiology
|
November 14, 2023
Field-Based Planetary Protection Operations for Melt Probes: Validation of Clean Access into the Blood Falls, Antarctica, Englacial Ecosystem
J A Mikucki, C G Schuler, I Digel, et al.
Page
of 51
Search research articles
Search
Showing results (461-470 of 510) with videos related to
Sort By:
Page
of 51
Current Biology : CB
|
August 30, 2001
A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells
O T Fackler, D Wolf, H O Weber, et al.
Journal of Immunological Methods
|
October 24, 2000
A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use
B Feuerstein, T G Berger, C Maczek, et al.
British Journal of Cancer
|
March 1, 2002
Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)
J Atzpodien, K Neuber, D Kamanabrou, et al.
Der Radiologe
|
October 17, 2013
[Imaging prior to transcatheter aortic valve implantation]
M Gutberlet, B Foldyna, M Grothoff, et al.
The British Journal of Dermatology
|
July 15, 2017
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients
Y Teramoto, U Keim, A Gesierich, et al.
The Journal of Experimental Medicine
|
December 10, 1999
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
B Thurner, I Haendle, C Röder, et al.
Science (New York, N.Y.)
|
January 5, 1999
The transcriptional program in the response of human fibroblasts to serum
V R Iyer, M B Eisen, D T Ross, et al.
Journal of Cancer Research and Clinical Oncology
|
June 16, 2017
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab
C Brüggemann, M C Kirchberger, S M Goldinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells
B Schuler-Thurner, D Dieckmann, P Keikavoussi, et al.
Astrobiology
|
November 14, 2023
Field-Based Planetary Protection Operations for Melt Probes: Validation of Clean Access into the Blood Falls, Antarctica, Englacial Ecosystem
J A Mikucki, C G Schuler, I Digel, et al.
Page
of 51